UOC
RXDX

UBS O'Connor’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

UBS O'Connor’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24,000
Closed -$678K – 1018
2022
Q2 		$678K Buy
+24,000
New +$678K 0.01% 783